REN Mouse

Renin Mouse Recombinant
Shipped with Ice Packs
In Stock

Description

RenMab™ Mouse

  • Description: Fully humanized mouse with in situ replacement of murine heavy and kappa light chain V(D)J loci with human counterparts, retaining murine constant regions .

  • Key Features:

    • Produces monoclonal antibodies with high diversity and affinity.

    • Maintains a normal immune system comparable to wild-type mice .

  • Applications:

    • Discovery of fully human monoclonal antibodies (e.g., anti-cancer, autoimmune, and infectious disease targets) .

RenLite® Mouse

  • Description: Combines human heavy chain variable regions with a single human kappa light chain VJ locus, enabling efficient assembly of bispecific antibodies .

  • Key Features:

    • Eliminates light chain mispairing during bispecific antibody development.

    • Supports anti-GPCR antibodies and TCR-mimic antibodies .

  • Applications:

    • Development of bispecific antibody-drug conjugates (bsADCs) and CAR-T therapies .

RenNano® Mouse

  • Description: Generates heavy-chain-only antibodies (HCAbs) with modified constant regions, enabling single-domain antibodies (sdAbs) or nanobodies .

  • Key Features:

    • Exhibits normal B cell development and robust immune responses.

    • Produces HCAbs with longer CDR3 regions and nanomolar-level affinity .

  • Applications:

    • Construction of bispecific/multispecific antibodies and CAR cell therapies .

Antibody Diversity and Affinity

RenNano-derived HCAbs demonstrate exceptional diversity and binding kinetics:

TargetAffinity (nM)Source
4-1BB0.1–10
TROP20.1–10
IL3RA0.1–10
PSMA0.1–10

Immune Response Efficiency

RenNano mice show robust responses to diverse antigens:

  • Membrane Antigens: TFR1, 4-1BB (validated via flow cytometry) .

  • Secreted Antigens: ALB (measured via ELISA) .

B Cell Development

ParameterRenNanoWild-Type
Spleen B Cell %~50%~50%
F follicular B %~70%~70%
MZ B Cell %~20%~20%
Data from

Therapeutic Modalities

  • RenMab™: Monoclonal antibodies (e.g., anti-PD-1, anti-VEGF) .

  • RenLite®: Bispecific T-cell engagers (e.g., CD3/CD19) .

  • RenNano®: Nanobodies for imaging or targeted toxin delivery .

Industry Collaborations

Biocytogen has licensed RenMice platforms to major pharmaceutical companies:

PartnerPlatformPurpose
MerckRenMab™Fully human antibody discovery
BeiGeneRenMab™Bispecific antibody development
XencorRenLite®Multispecific antibody engineering
JanssenRenLite®CAR-T therapy innovation
Data from

Renin Kinetics in Transgenic Models

While not directly related to the antibody platforms, studies on hypertension in (mRen-2)27 rats highlight complexities in renin-angiotensin system (RAS) interactions. Key findings include:

  • Kinetic Similarity: Mouse Ren-2 and rat renin showed comparable K<sub>cat</sub>/ K<sub>m</sub> values when acting on rat angiotensinogen (0.04 vs. 0.05 L·μmol⁻¹·s⁻¹) .

  • Hypertension Drivers: Tissue RAS activation, not kinetic efficiency, likely explains hypertension in transgenic models .

Limitations in Substrate Availability

Mice exhibit low circulating angiotensinogen, making substrate availability a rate-limiting factor for angiotensin II production . This contrasts with humans and rats, where renin is the primary regulator .

Product Specs

Introduction
Renin is a highly specific enzyme that plays a crucial role in regulating blood pressure and electrolyte balance. It acts by cleaving angiotensinogen, a protein circulating in the bloodstream, to generate angiotensin I. This process initiates a series of reactions that ultimately lead to an increase in blood pressure and sodium retention by the kidneys.
Description
Recombinant Mouse Renin (REN) is produced in Sf9 insect cells using a baculovirus expression system. This protein is a single, glycosylated polypeptide chain that contains 387 amino acids (amino acids 22-402 of the full-length protein) and has a molecular weight of 42.5 kDa. On SDS-PAGE under reducing conditions, REN migrates between 40-57 kDa due to glycosylation. The protein is expressed with a 6-amino acid Histidine tag at the C-terminus to facilitate purification using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The REN protein is supplied as a solution at a concentration of 0.25 mg/ml in Phosphate Buffered Saline (PBS) with a pH of 7.4 and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), keep the REN protein solution refrigerated at 4°C. For long-term storage, it is recommended to freeze the solution at -20°C. To ensure stability during long-term storage, adding a carrier protein like HSA or BSA to a final concentration of 0.1% is advisable. Avoid repeated freezing and thawing of the protein solution to prevent degradation.
Purity
The purity of the REN protein is greater than 95%, as determined by SDS-PAGE analysis.
Synonyms
Renin-1, Angiotensinogenase, Kidney renin, Ren1, Ren, Ren-A, Ren1c, Ren1d, Rn-1, Rnr.
Source
Sf9, Baculovirus cells.
Amino Acid Sequence
LPTRTATFER IPLKKMPSVR EILEERGVDM TRLSAEWGVF TKRPSLTNLT SPVVLTNYLN TQYYGEIGIG TPPQTFKVIF DTGSANLWVP STKCSRLYLA CGIHSLYESS DSSSYMENGS DFTIHYGSGR VKGFLSQDSV TVGGITVTQT FGEVTELPLI PFMLAKFDGV LGMGFPAQAV GGVTPVFDHI LSQGVLKEEV FSVYYNRGSH LLGGEVVLGG SDPQHYQGNF HYVSISKTDS WQITMKGVSV GSSTLLCEEG CAVVVDTGSS FISAPTSSLK LIMQALGAKE KRIEEYVVNC SQVPTLPDIS FDLGGRAYTL SSTDYVLQYP NRRDKLCTLA LHAMDIPPPT GPVWVLGATF IRKFYTEFDR HNNRIGFALA RHHHHHH.

Q&A

What are the primary REN mouse models available for cardiovascular research?

Several REN mouse models have been developed for cardiovascular research, with the most significant being the Ren-2 gene knockout mice and the newer humanized REN mouse platforms. The targeted inactivation of the Ren-2 gene in strain 129 mice produces viable and healthy subjects that allow for direct evaluation of the Ren-1d gene's ability to regulate blood pressure in the absence of Ren-2 enzyme expression . This model is particularly valuable for studying the physiological significance of the duplicated renin gene found in wild mouse strains and some inbred laboratory strains. Additionally, more advanced platforms like RenMab, RenLite, and RenNano humanized mice have been developed for specialized antibody discovery applications targeting the renin-angiotensin system .

What are the fundamental differences between the major types of humanized REN mouse platforms?

Each humanized REN mouse platform has been engineered with specific research applications in mind:

Mouse ModelGenetic ModificationKey FeaturesPrimary Research Applications
RenMab™Complete replacement of murine variable regions with full human heavy and kappa light chain V(D)J lociNormal immune system comparable to wild-type mice, greater diversity of antibody genesDiscovery of fully human therapeutic antibodies
RenLite®Replacement of murine heavy chain variable regions with human ones, plus replacement of one κ light chain VJ locusDiverse epitopes and high affinities, more efficient downstream assembly of complex drug moleculesBispecific antibodies and bispecific antibody-drug conjugates (bsADCs)
RenNano®Complete human heavy chain variable genes with modified mouse constant regionsGenerates heavy-chain-only antibodies (HCAbs) with great diversity and nM-level binding affinitySingle-domain antibodies (sdAbs), bispecific/multispecific antibodies, CAR cell therapies
RenTCR-mimic™Further modified to express human leukocyte antigen (HLA) genesHigh specificity and affinity against intracellular tumor antigensT cell engagers, bispecific/multispecific antibodies, CAR-T therapies

These platforms enable researchers to address various aspects of renin biology through antibody-based approaches .

What are the optimal methods for quantifying renin expression in mouse models?

For precise quantification of renin expression in mouse models, the recommended approach is using a high-sensitivity enzyme-linked immunosorbent assay (ELISA) specifically designed for mouse REN. The Mouse REN (Renin) ELISA Kit offers outstanding precision with a detection range of 7.81-500 pg/mL and sensitivity of 4.52 pg/mL . For optimal results, the following methodology is recommended:

  • Sample collection: Obtain serum, plasma, or other biological fluids (25 μL sample volume is typically sufficient)

  • Assay procedure: Follow the sandwich ELISA protocol, which typically requires approximately 3.5 hours

  • Quality control: Ensure specificity by confirming no significant cross-reactivity between Mouse REN and analogues

  • Data analysis: Calculate concentration using the standard curve generated during the assay

This approach enables accurate measurement of renin levels crucial for investigating blood pressure regulation, vascular function, and electrolyte balance in mouse models .

How can researchers effectively design experiments to study the role of Ren genes in blood pressure regulation?

When designing experiments to study Ren genes' role in blood pressure regulation, researchers should implement a multi-faceted approach:

  • Baseline characterization: Establish baseline blood pressure measurements in both wild-type and Ren-modified mice using either tail-cuff plethysmography (for non-invasive screening) or telemetry (for continuous monitoring)

  • Challenge testing: Subject mice to physiological challenges that stress the renin-angiotensin system:

    • Salt loading and salt restriction to evaluate adaptive responses

    • Angiotensin II infusion to test downstream pathway responsiveness

    • Dehydration/rehydration cycles to assess dynamic regulation

  • Comparative analysis: Include both Ren-2 null mice and control mice to directly evaluate the ability of Ren-1d gene to regulate blood pressure in the absence of Ren-2 expression

  • Biochemical profiling: Measure both active renin and prorenin concentrations in plasma, as Ren-2 null mice show increased active renin but decreased prorenin levels

  • Tissue expression mapping: Perform histopathological analysis of renin-expressing tissues to identify potential compensatory mechanisms

This comprehensive experimental design allows for robust investigation of the functional equivalence between different Ren genes and their compensatory mechanisms in blood pressure regulation.

How can researchers leverage REN mouse models for developing therapeutics targeting the renin-angiotensin system?

Researchers can strategically utilize REN mouse models for therapeutic development through several advanced approaches:

  • Target validation: Use Ren-2 null mice to validate the specific contributions of renin isoforms to pathophysiological processes, enabling precise targeting in drug development

  • Antibody development pipeline: Implement a systematic approach using humanized REN mouse platforms:

    • Initial immunization and screening using RenMab mice to generate diverse, fully human antibodies against renin targets

    • Further refinement through RenLite mice for development of bispecific antibodies that can simultaneously target multiple components of the renin-angiotensin system

    • Utilization of RenNano mice to develop single-domain antibodies with superior tissue penetration for targeting previously inaccessible renin-expressing tissues

  • Therapeutic screening: Test candidate therapeutics in the Ren-2 null model to assess efficacy in a system where blood pressure regulation depends solely on Ren-1d expression

  • Combination therapies: Develop multi-modal approaches that target different components of the renin-angiotensin-aldosterone system simultaneously

This integrated approach enables comprehensive therapeutic development targeting the renin-angiotensin system from initial discovery through preclinical validation.

What are the advanced techniques for spatial mapping of renin expression patterns in REN mouse models?

Advanced spatial mapping of renin expression requires sophisticated techniques that preserve both molecular and spatial information:

  • Multiplexed error-robust fluorescence in situ hybridization (MERFISH): This cutting-edge technique allows visualization and annotation of spatial locations of renin-expressing cells with single-cell resolution. The technique can be integrated with brain coordinate frameworks (like the Allen Mouse Brain Common Coordinate Framework) to precisely map expression patterns

  • Single-cell RNA sequencing (scRNA-seq) combined with anatomical microdissection: This approach begins with anatomically defined, guided tissue microdissections followed by scRNA-seq to create high-resolution transcriptomic profiles of renin-expressing cells

  • Integration of transcriptomic and spatial data: By combining scRNA-seq data with MERFISH spatial data, researchers can develop comprehensive atlases that reveal both the molecular identity and spatial distribution of renin-expressing cells

  • Hierarchical classification: Analysis can be structured into nested levels (e.g., classes, subclasses, supertypes, and clusters) to fully characterize the cellular diversity of renin-expressing populations

These advanced spatial mapping techniques enable unprecedented insights into the heterogeneity and regional specialization of renin-expressing cells within different tissues.

How do transcription factors influence cell-type specificity in renin-expressing cells of REN mouse models?

Transcription factors play a crucial role in determining cell-type specification and maintenance in renin-expressing cells. Recent comprehensive transcriptomic and spatial atlases of mouse cells have revealed:

  • Combinatorial transcription factor codes: Specific combinations of transcription factors define cell types across all parts of the brain and other tissues. For renin-expressing cells, these combinatorial codes determine their identity and functional properties

  • Regional heterogeneity: Renin-expressing cells show varying transcription factor expression patterns depending on their anatomical location, contributing to their functional specialization in different tissues

  • Regulatory networks: Transcription factors operate within complex regulatory networks that control the expression of renin and other components of the renin-angiotensin system

  • Developmental programming: Specific transcription factor cascades guide the development and maturation of renin-expressing cells during organogenesis

Understanding these transcription factor networks provides opportunities for targeted manipulation of renin expression in specific cell populations, offering potential therapeutic avenues for hypertension and other cardiovascular disorders.

How should researchers interpret apparent contradictions in renin expression data between different REN mouse models?

When faced with contradictory renin expression data between different mouse models, researchers should employ a systematic analytical approach:

  • Consider genetic background effects: Different mouse strains may have varying compensatory mechanisms that affect renin expression. For instance, mice with the Ren-2 gene inactivated demonstrate different renin dynamics than single-renin gene models

  • Evaluate methodology-induced variations:

    • Sample processing techniques can significantly impact renin measurements

    • The sensitivity and specificity of detection methods vary (ELISA sensitivity of 4.52 pg/mL versus other methods)

    • Timing of sample collection may capture different phases of renin expression cycles

  • Analyze differential tissue expression: Renin expression varies significantly across tissues, and the Ren-1d gene has a different tissue expression profile than Ren-2

  • Account for active renin versus prorenin ratios: Ren-2 null mice show increased active renin but decreased prorenin levels in plasma, which might lead to seemingly contradictory results depending on what form is being measured

  • Validate with multiple techniques: Combine ELISA quantification with transcriptomic analysis and spatial mapping techniques like MERFISH to develop a comprehensive understanding of renin expression patterns

This structured approach helps reconcile apparent contradictions and develops a more nuanced understanding of renin biology across different mouse models.

What statistical approaches are most appropriate for analyzing complex datasets from REN mouse experiments?

Complex datasets from REN mouse experiments require sophisticated statistical approaches:

  • For transcriptomic data analysis:

    • Implement iterative clustering analysis for single-cell transcriptomic data to identify cell types and states

    • Perform pairwise cluster comparisons to identify differentially expressed genes (DEGs) associated with renin function

    • Apply dimensionality reduction techniques (e.g., t-SNE, UMAP) to visualize relationships between cell populations

  • For spatial data integration:

    • Utilize computational integration methods to align transcriptomic data with spatial coordinates

    • Apply spatial statistics to identify regional specialization of renin-expressing cells

  • For phenotypic and physiological measurements:

    • Implement mixed-effects models to account for within-subject correlation in longitudinal blood pressure data

    • Use ANOVA with appropriate post-hoc tests when comparing multiple experimental groups

    • Apply non-parametric alternatives when data violate normality assumptions

  • For validation and reproducibility:

    • Calculate both intra-assay and inter-assay coefficients of variation to ensure reliability of renin measurements

    • Implement false discovery rate corrections for multiple comparisons in high-dimensional data

These statistical approaches ensure robust, reproducible findings from complex REN mouse experiments while minimizing false positives and appropriately handling the multilayered nature of modern biomedical data.

How might single-cell technologies further advance our understanding of the renin-angiotensin system in REN mouse models?

Single-cell technologies offer unprecedented opportunities to advance renin-angiotensin system research:

  • Single-cell multi-omics integration: Combining single-cell transcriptomics with proteomics and epigenomics will provide comprehensive molecular profiles of renin-expressing cells. This integration can reveal how transcriptional, post-transcriptional, and epigenetic mechanisms collectively regulate renin expression and function

  • Spatial transcriptomics advancement: Further development of MERFISH and other spatial technologies will enable three-dimensional mapping of renin-expressing cells with subcellular resolution, revealing the precise tissue architecture and cellular neighborhoods that influence renin production

  • Temporal dynamics analysis: Applying single-cell RNA velocity analysis to REN mouse data can reveal developmental trajectories and dynamic state transitions of renin-expressing cells under various physiological and pathological conditions

  • Single-cell CRISPR screens: Implementing pooled CRISPR screens at single-cell resolution in REN mouse models will enable systematic identification of genes that regulate renin expression and function

  • Computational modeling: Integrating single-cell data with physiological measurements will enable the development of multi-scale computational models that predict how cellular-level changes in renin expression propagate to systemic effects on blood pressure regulation

These advanced single-cell approaches will provide unprecedented insights into the cellular and molecular heterogeneity underlying the renin-angiotensin system, potentially revealing new therapeutic targets for cardiovascular and renal diseases.

What emerging genetic engineering approaches might enhance REN mouse models for therapeutic discovery?

Several cutting-edge genetic engineering approaches show promise for enhancing REN mouse models:

  • CRISPR-Cas9 base editing and prime editing: These precise genome editing technologies allow for seamless introduction of specific mutations in renin genes without double-strand breaks, enabling the creation of more refined disease models that mimic human renin polymorphisms

  • Conditional and inducible renin expression systems: Advanced genetic switches can enable temporal and spatial control of renin expression, allowing researchers to study acute versus chronic effects of renin dysregulation in specific tissues

  • Humanized renin-angiotensin system models: Creating mice with fully humanized renin-angiotensin components would better recapitulate human biology and improve translational relevance of findings

  • Reporter systems for live imaging: Integrating fluorescent or bioluminescent reporters into endogenous renin loci would enable real-time, non-invasive monitoring of renin expression dynamics in living animals

  • Tissue-specific humanization: Development of tissue-selective REN humanized mice that express human renin only in relevant tissues (kidney juxtaglomerular cells, brain, adrenal gland) would provide more precise models for studying tissue-specific renin functions

These emerging genetic engineering approaches hold tremendous potential for creating next-generation REN mouse models that more accurately reflect human renin biology and pathophysiology, accelerating therapeutic discovery for hypertension and related cardiovascular disorders.

Product Science Overview

Introduction

Renin, also known as REN or angiotensinogenase, is a circulating enzyme that plays a crucial role in the body’s renin-angiotensin system (RAS). This system is essential for regulating blood pressure and fluid balance in the body. The recombinant form of renin from mice is often used in research to study its functions and potential therapeutic applications.

Gene and Expression

The gene encoding renin is localized on mouse chromosome 1. In recombinant studies, renin is typically expressed in HEK 293 cells, which are human embryonic kidney cells. This expression system is chosen because it allows for proper folding and post-translational modifications of the protein, ensuring that the recombinant renin closely mimics the natural enzyme .

Structure and Properties

Renin is a protease enzyme with a calculated molecular weight of approximately 43.2 kDa. However, due to glycosylation, the observed molecular weight can range between 45-55 kDa when analyzed by SDS-PAGE under reducing conditions. The enzyme is often tagged with a 6-His tag at the C-terminus to facilitate purification .

Biological Function

Renin’s primary function is to activate the renin-angiotensin system by cleaving angiotensinogen, a protein produced by the liver, to yield angiotensin I. Angiotensin I is then converted into angiotensin II by the angiotensin-converting enzyme (ACE), primarily within the capillaries of the lungs. Angiotensin II is a potent vasoconstrictor that increases blood pressure and stimulates the release of aldosterone, which promotes sodium retention by the kidneys .

Physiological Role

Renin plays an essential role in the elevation of arterial blood pressure and increased sodium retention by the kidney. It is a key regulator of blood pressure and electrolyte balance, making it a critical target for antihypertensive therapies. Dysregulation of renin activity can lead to conditions such as hypertension and congestive heart failure .

Research and Applications

Recombinant mouse renin is widely used in research to study the mechanisms of blood pressure regulation and to develop new treatments for hypertension and related cardiovascular diseases. It is also used in the development of renin inhibitors, which are a class of antihypertensive drugs that directly inhibit the activity of renin .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.